Nanoparticles and the blood coagulation system. Part II: safety concerns

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Ilinskaya AN, Dobrovolskaia MA. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology. Nanomedicine (Lond.)8(5),773–784 (2013).
  CASGoogle Scholar
• 2  Brook RD, Rajagopalan S, Pope CA 3rd et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation121(21),2331–2378 (2010).
  Medline CASGoogle Scholar
• 3  Rückerl R, Ibald-Mulli A, Koenig W et al. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am. J. Respir. Crit. Care Med.173(4),432–441 (2006).
  Medline CASGoogle Scholar
• 4  Baccarelli A, Martinelli I, Zanobetti A et al. Exposure to particulate air pollution and risk of deep vein thrombosis. Arch. Intern. Med.168(9),920–927 (2008).
  MedlineGoogle Scholar
• 5  Utell MJ, Frampton MW, Zareba W, Devlin RB, Cascio WE. Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal. Toxicol.14(12),1231–1247 (2002).
  Medline CASGoogle Scholar
• 6  Furie B, Furie BC. Mechanisms of thrombus formation. N. Engl. J. Med.359(9),938–949 (2008).
  Medline CASGoogle Scholar
• 7  Greish K, Thiagarajan G, Herd H et al. Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology6(7),713–723. (2011).
  MedlineGoogle Scholar
• 8  Nabeshi H, Yoshikawa T, Matsuyama K et al. Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure. Nanotechnology23(4),045101 (2012).
  MedlineGoogle Scholar
• 9  Radomski A, Jurasz P, Alonso-Escolano D et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol.146(6),882–893 (2005).▪▪ Reported that nanoparticles activate platelets through a nontraditional pathway.
  Medline CASGoogle Scholar
• 10  Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Frohlich E. The role of nanoparticle size in hemocompatibility. Toxicology258(2–3),139–147 (2009).
  Medline CASGoogle Scholar
• 11  Nel AE, Madler L, Velegol D et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater.8(7),543–557 (2009).
  Medline CASGoogle Scholar
• 12  Tenzer S, Docter D, Rosfa S et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano5(9),7155–7167 (2011).
  Medline CASGoogle Scholar
• 13  Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl Acad. Sci. USA105(38),14265–14270 (2008).▪ Provides an overview of protein corona and relates it to nanoparticle biocompatibility.
  Medline CASGoogle Scholar
• 14  Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev.61(6),428–437 (2009).
  Medline CASGoogle Scholar
• 15  Sperling C, Fischer M, Maitz MF, Werner C. Blood coagulation on biomaterials requires the combination of distinct activation processes. Biomaterials30(27),4447–4456 (2009).▪ Reviews interactions between biomaterials and the coagulation system, and discusses the role of surface in hematocompatibility.
  Medline CASGoogle Scholar
• 16  Oslakovic C, Cedervall T, Linse S, Dahlback B. Polystyrene nanoparticles affecting blood coagulation. Nanomedicine8(6),981–986 (2012).▪ Demonstrates that activation or inhibition of the coagulation system depends on nanoparticle surface properties.
  Medline CASGoogle Scholar
• 17  Malik N, Wiwattanapatapee R, Klopsch R et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of ¹²⁵I-labelled polyamidoamine dendrimers in vivo. J. Control. Release65(1–2),133–148 (2000).
  Medline CASGoogle Scholar
• 18  Stasko NA, Johnson CB, Schoenfisch MH, Johnson TA, Holmuhamedov EL. Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. Biomacromolecules8(12),3853–3859 (2007).
  Medline CASGoogle Scholar
• 19  Dobrovolskaia MA, Patri AK, Potter TM, Rodriguez JC, Hall JB, McNeil SE. Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge. Nanomedicine (Lond.)7(2),245–256 (2012).▪ Shows that nanoparticles can exaggerate the thrombogenicity of an inflammatory stimulus.
  CASGoogle Scholar
• 20  Dobrovolskaia MA, Patri AK, Simak J et al. Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro. Mol. Pharm.9(3),382–393 (2011).
  MedlineGoogle Scholar
• 21  Jones CF, Campbell RA, Franks Z et al. Cationic PAMAM dendrimers disrupt key platelet functions. Mol. Pharm.9(6),1599–1611 (2012).
  Medline CASGoogle Scholar
• 22  Inoue K, Takano H. Aggravating impact of nanoparticles on immune-mediated pulmonary inflammation. ScientificWorldJournal11,382–390 (2011).
  Medline CASGoogle Scholar
• 23  Inoue K, Takano H, Yanagisawa R, Koike E, Shimada A. Size effects of latex nanomaterials on lung inflammation in mice. Toxicol. Appl. Pharmacol.234(1),68–76 (2009).
  Medline CASGoogle Scholar
• 24  Inoue K. Promoting effects of nanoparticles/materials on sensitive lung inflammatory diseases. Environ. Health Prev. Med.16(3),139–143 (2011).
  Medline CASGoogle Scholar
• 25  McGuinnes C, Duffin R, Brown S et al. Surface derivatization state of polystyrene latex nanoparticles determines both their potency and their mechanism of causing human platelet aggregation in vitro. Toxicol. Sci.119(2),359–368 (2011).
  Medline CASGoogle Scholar
• 26  Juliano RL, Hsu MJ, Peterson D, Regen SL, Singh A. Interactions of conventional or photopolymerized liposomes with platelets in vitro. Exp. Cell Res.146(2),422–427 (1983).
  Medline CASGoogle Scholar
• 27  Koziara JM, Oh JJ, Akers WS, Ferraris SP, Mumper RJ. Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm. Res.22(11),1821–1828 (2005).
  Medline CASGoogle Scholar
• 28  Zbinden G, Wunderli-Allenspach H, Grimm L. Assessment of thrombogenic potential of liposomes. Toxicology54(3),273–280 (1989).
  Medline CASGoogle Scholar
• 29  Constantinescu I, Levin E, Gyongyossy-Issa M. Liposomes and blood cells: a flow cytometric study. Artif. Cells Blood Substit. Immobil. Biotechnol.31(4),395–424 (2003).
  Medline CASGoogle Scholar
• 30  Male R, Vannier WE, Baldeschwieler JD. Phagocytosis of liposomes by human platelets. Proc. Natl Acad. Sci. USA89(19),9191–9195 (1992).
  Medline CASGoogle Scholar
• 31  Nishiya T, Lam RT, Eng F, Zerey M, Lau S. Mechanistic study on toxicity of positively charged liposomes containing stearylamine to blood. Artif. Cells Blood Substit. Immobil. Biotechnol.23(4),505–512 (1995).
  Medline CASGoogle Scholar
• 32  Nishiya T, Sloan S. Interaction of RGD liposomes with platelets. Biochem. Biophys. Res. Commun.224(1),242–245 (1996).
  Medline CASGoogle Scholar
• 33  Reinish LW, Bally MB, Loughrey HC, Cullis PR. Interactions of liposomes and platelets. Thromb. Haemost.60(3),518–523 (1988).
  Medline CASGoogle Scholar
• 34  Dabbas S, Kaushik RR, Dandamudi S, Kuesters GM, Campbell RB. Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells. Endothelium15(4),189–201 (2008).
  Medline CASGoogle Scholar
• 35  Campbell RB, Fukumura D, Brown EB et al. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res.62(23),6831–6836 (2002).
  Medline CASGoogle Scholar
• 36  Krasnici S, Werner A, Eichhorn ME et al. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int. J. Cancer105(4),561–567 (2003).
  Medline CASGoogle Scholar
• 37  Lowe KC, Bentley PK. Retention of perfluorochemicals in rat liver and spleen. Biomater. Artif. Cells Immobilization Biotechnol.20(2–4),1029–1031 (1992).
  Medline CASGoogle Scholar
• 38  Mitsuno T, Ohyanagi H. Present status of clinical studies of Fluosol-DA (20%) in Japan. Int. Anesthesiol. Clin.23(1),169–184 (1985).
  Medline CASGoogle Scholar
• 39  Vercellotti GM, Hammerschmidt DE, Craddock PR, Jacob HS. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis. Blood59(6),1299–1304 (1982).
  Medline CASGoogle Scholar
• 40  Cuignet OY, Wood BL, Chandler WL, Spiess BD. A second-generation blood substitute (perfluorodichlorooctane emulsion) generates spurious elevations in platelet counts from automated hematology analyzers. Anesth. Analg.90(3),517–522 (2000).
  Medline CASGoogle Scholar
• 41  Thomson H, Ali A, Harper NJ. Spurious propofol-induced coagulopathy in a patient with hepatic rupture. Anaesthesia63(9),1024–1025 (2008).
  Medline CASGoogle Scholar
• 42  Beule AG, Wilhelmi F, Kuhnel TS, Hansen E, Lackner KJ, Hosemann W. Propofol versus sevoflurane: bleeding in endoscopic sinus surgery. Otolaryngol. Head Neck Surg.136(1),45–50 (2007).
  MedlineGoogle Scholar
• 43  Barregard L, Sallsten G, Andersson L et al. Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress. Occup. Environ. Med.65(5),319–324 (2008).
  Medline CASGoogle Scholar
• 44  Nemmar A, Hoylaerts MF, Hoet PH, Nemery B. Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol. Lett.149(1–3),243–253 (2004).
  Medline CASGoogle Scholar
• 45  Ravichandran P, Baluchamy S, Gopikrishnan R et al. Pulmonary biocompatibility assessment of inhaled single-wall and multiwall carbon nanotubes in BALB/c mice. J. Biol. Chem.286(34),29725–29733 (2011).
  Medline CASGoogle Scholar
• 46  Li N, Xia T, Nel AE. The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic. Biol. Med.44(9),1689–1699 (2008).
  Medline CASGoogle Scholar
• 47  Pourazar J, Mudway IS, Samet JM et al. Diesel exhaust activates redox-sensitive transcription factors and kinases in human airways. Am. J. Physiol. Lung Cell. Mol. Physiol.289(5),L724–L730 (2005).
  Medline CASGoogle Scholar
• 48  Salvi S, Blomberg A, Rudell B et al. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am. J. Respir. Crit. Care Med.159(3),702–709 (1999).
  Medline CASGoogle Scholar
• 49  Salvi SS, Nordenhall C, Blomberg A et al. Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways. Am. J. Respir. Crit. Care Med.161(2 Pt 1),550–557 (2000).
  Medline CASGoogle Scholar
• 50  Baulig A, Garlatti M, Bonvallot V et al. Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol.285(3),L671–L679 (2003).
  Medline CASGoogle Scholar
• 51  Alfaro-Moreno E, Nawrot TS, Nemmar A, Nemery B. Particulate matter in the environment: pulmonary and cardiovascular effects. Curr. Opin. Pulm. Med.13(2),98–106 (2007).
  MedlineGoogle Scholar
• 52  Erdely A, Hulderman T, Salmen R et al. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett.9(1),36–43 (2009).
  Medline CASGoogle Scholar
• 53  Levi M, Schultz M, van der Poll T. Disseminated intravascular coagulation in infectious disease. Semin. Thromb. Hemost.36(4),367–377 (2010).
  Medline CASGoogle Scholar
• 54  Liao D, Heiss G, Chinchilli VM et al. Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study. J. Expo. Anal. Environ. Epidemiol.15(4),319–328 (2005).
  Medline CASGoogle Scholar
• 55  Ghio AJ, Hall A, Bassett MA, Cascio WE, Devlin RB. Exposure to concentrated ambient air particles alters hematologic indices in humans. Inhal. Toxicol.15(14),1465–1478 (2003).
  Medline CASGoogle Scholar
• 56  Nemmar A, Delaunois A, Nemery B et al. Inflammatory effect of intratracheal instillation of ultrafine particles in the rabbit: role of C-fiber and mast cells. Toxicol. Appl. Pharmacol.160(3),250–261 (1999).
  Medline CASGoogle Scholar
• 57  Berry JP, Arnoux B, Stanislas G, Galle P, Chretien J. A microanalytic study of particles transport across the alveoli: role of blood platelets. Biomedicine27(9–10),354–357 (1977).
  Medline CASGoogle Scholar
• 58  Nemmar A, Hoet PH, Vanquickenborne B et al. Passage of inhaled particles into the blood circulation in humans. Circulation105(4),411–414 (2002).
  Medline CASGoogle Scholar
• 59  Mills NL, Amin N, Robinson SD et al. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am. J. Respir. Crit. Care Med.173(4),426–431 (2006).
  MedlineGoogle Scholar
• 60  Nemmar A, Hoet PH, Dinsdale D, Vermylen J, Hoylaerts MF, Nemery B. Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation107(8),1202–1208 (2003).
  MedlineGoogle Scholar
• 61  Inoue K, Takano H, Yanagisawa R, Ichinose T, Shimada A, Yoshikawa T. Pulmonary exposure to diesel exhaust particles induces airway inflammation and cytokine expression in NC/Nga mice. Arch. Toxicol.79(10),595–599 (2005).
  Medline CASGoogle Scholar
• 62  Silva VM, Corson N, Elder A, Oberdorster G. The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol. Sci.85(2),983–989 (2005).
  Medline CASGoogle Scholar
• 63  Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci.77(1),126–134 (2004).
  Medline CASGoogle Scholar
• 64  Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci.77(1),117–125 (2004).
  Medline CASGoogle Scholar
• 65  Shvedova AA, Kisin ER, Mercer R et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol. Physiol.289(5),L698–L708 (2005).
  Medline CASGoogle Scholar
• 66  Bihari P, Holzer M, Praetner M et al. Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation. Toxicology269(2–3),148–154 (2010).
  Medline CASGoogle Scholar
• 67  Semberova J, De Paoli Lacerda SH, Simakova O, Holada K, Gelderman MP, Simak J. Carbon nanotubes activate blood platelets by inducing extracellular Ca²⁺ influx sensitive to calcium entry inhibitors. Nano Lett.9(9),3312–3317 (2009).▪ Discusses the mechanisms underlying platelet activation by carbon nanotubes.
  Medline CASGoogle Scholar
• 68  Lacerda SH, Semberova J, Holada K, Simakova O, Hudson SD, Simak J. Carbon nanotubes activate store-operated calcium entry in human blood platelets. ACS Nano5(7),5808–5813 (2011).
  MedlineGoogle Scholar
• 69  Khandoga A, Stoeger T, Khandoga AG et al. Platelet adhesion and fibrinogen deposition in murine microvessels upon inhalation of nanosized carbon particles. J. Thromb. Haemost.8(7),1632–1640 (2010).
  Medline CASGoogle Scholar
• 70  Khandoga A, Stampfl A, Takenaka S et al. Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation109(10),1320–1325 (2004).
  MedlineGoogle Scholar
• 71  Burke AR, Singh RN, Carroll DL et al. Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Biomaterials32(26),5970–5978 (2011).
  Medline CASGoogle Scholar
• 72  Walker VG, Li Z, Hulderman T, Schwegler-Berry D, Kashon ML, Simeonova PP. Potential in vitro effects of carbon nanotubes on human aortic endothelial cells. Toxicol. Appl. Pharmacol.236(3),319–328 (2009).
  Medline CASGoogle Scholar
• 73  Yamawaki H, Iwai N. Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells. Circ. J.70(1),129–140 (2006).
  Medline CASGoogle Scholar
• 74  Vallhov H, Qin J, Johansson SM et al. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett.6(8),1682–1686 (2006).
  Medline CASGoogle Scholar
• 75  Pulskamp K, Diabate S, Krug HF. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol. Lett.168(1),58–74 (2007).
  Medline CASGoogle Scholar
• 76  Pericleous P, Gazouli M, Lyberopoulou A, Rizos S, Nikiteas N, Efstathopoulos EP. Quantum dots hold promise for early cancer imaging and detection. Int. J. Cancer131(3),519–528 (2012).
  Medline CASGoogle Scholar
• 77  Geys J, Nemmar A, Verbeken E et al. Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ. Health Perspect.116(12),1607–1613 (2008).
  Medline CASGoogle Scholar
• 78  Ramot Y, Steiner M, Morad V et al. Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells. Nanotoxicology4(1),98–105 (2010).
  Medline CASGoogle Scholar
• 79  Yan M, Zhang Y, Xu K, Fu T, Qin H, Zheng X. An in vitro study of vascular endothelial toxicity of CdTe quantum dots. Toxicology282(3),94–103 (2011).
  Medline CASGoogle Scholar
• 80  Wang L, Zhang J, Zheng Y, Yang J, Zhang Q, Zhu X. Bioeffects of CdTe quantum dots on human umbilical vein endothelial cells. J. Nanosci. Nanotechnol.10(12),8591–8596 (2010).
  Medline CASGoogle Scholar
• 81  Chen G, Ni N, Zhou J et al. Fibrinogen clot induced by gold-nanoparticle in vitro. J. Nanosci. Nanotechnol.11(1),74–81 (2011).
  Medline CASGoogle Scholar
• 82  Dobrovolskaia MA, Patri AK, Zheng J et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine5(2),106–117 (2009).
  Medline CASGoogle Scholar
• 83  Deb S, Patra HK, Lahiri P, Dasgupta AK, Chakrabarti K, Chaudhuri U. Multistability in platelets and their response to gold nanoparticles. Nanomedicine7(4),376–384 (2011).
  Medline CASGoogle Scholar
• 84  Bartczak D, Muskens OL, Nitti S, Sanchez-Elsner T, Millar TM, Kanaras AG. Interactions of human endothelial cells with gold nanoparticles of different morphologies. Small8(1),122–130 (2012).
  Medline CASGoogle Scholar
• 85  Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J. Nanopart. Res.12(7),2313–2333 (2010).
  Medline CASGoogle Scholar
• 86  Pan Y, Leifert A, Ruau D et al. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small5(18),2067–2076 (2009).
  Medline CASGoogle Scholar
• 87  Ragaseema VM, Unnikrishnan S, Kalliyana Krishnan V, Krishnan LK. The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces. Biomaterials33(11),3083–3092 (2012).
  Medline CASGoogle Scholar
• 88  Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano3(6),1357–1364 (2009).
  Medline CASGoogle Scholar
• 89  Shrivastava S, Singh SK, Mukhopadhyay A, Sinha AS, Mandal RK, Dash D. Negative regulation of fibrin polymerization and clot formation by nanoparticles of silver. Colloids Surf. B Biointerfaces82(1),241–246 (2011).
  Medline CASGoogle Scholar
• 90  Jun EA, Lim KM, Kim K et al. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology5(2),157–167 (2011).
  Medline CASGoogle Scholar
• 91  Guildford AL, Poletti T, Osbourne LH, Di Cerbo A, Gatti AM, Santin M. Nanoparticles of a different source induce different patterns of activation in key biochemical and cellular components of the host response. J. R. Soc. Interface6(41),1213–1221 (2009).
  Medline CASGoogle Scholar
• 92  Zhu MT, Feng WY, Wang B et al. Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. Toxicology247(2–3),102–111 (2008).
  Medline CASGoogle Scholar
• 93  Herrmann IK, Urner M, Hasler M et al. Iron core/shell nanoparticles as magnetic drug carriers: possible interactions with the vascular compartment. Nanomedicine (Lond.)6(7),1199–1213 (2011).
  CASGoogle Scholar
• 94  Simberg D, Zhang WM, Merkulov S et al. Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo. J. Control. Release140(3),301–305 (2009).
  Medline CASGoogle Scholar
• 95  Xia T, Kovochich M, Liong M et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano3(10),3273–3286 (2009).
  Medline CASGoogle Scholar
• 96  Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small3(8),1341–1346 (2007).
  Medline CASGoogle Scholar
• 97  Merget R, Bauer T, Kupper HU et al. Health hazards due to the inhalation of amorphous silica. Arch. Toxicol.75(11–12),625–634 (2002).
  Medline CASGoogle Scholar
• 98  Tavano R, Segat D, Reddi E et al. Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomedicine (Lond.)5(6),881–896 (2010).
  CASGoogle Scholar
• 99  Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW. Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis. Int. J. Nanomed.7,631–639 (2012).
  CASGoogle Scholar
• 100  Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW. Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects. Int. J. Nanomed.6,2821–2835 (2011).
  Medline CASGoogle Scholar
• 101  Liu X, Sun J. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials31(32),8198–8209 (2010).
  Medline CASGoogle Scholar
• 102  Napierska D, Thomassen LC, Rabolli V et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small5(7),846–853 (2009).
  Medline CASGoogle Scholar
• 103  Bauer AT, Strozyk EA, Gorzelanny C et al. Cytotoxicity of silica nanoparticles through exocytosis of von Willebrand factor and necrotic cell death in primary human endothelial cells. Biomaterials32(33),8385–8393 (2011).
  Medline CASGoogle Scholar